To ensure the accuracy, reproducibility, and safety of the experiment, the following guidelines should be followed:
Use anticoagulants like EDTA or heparin to prevent clotting.
Process blood samples promptly (within 2–4 hours) to ensure neutrophil viability.
Ensure >95% cell viability using trypan blue or propidium iodide staining before proceeding with the assay.
Handle cells gently to avoid activation or damage.
Always include appropriate controls (negative control, positive control with PMA, and inhibitor control with DPI) to validate the experiment.
Use biological replicates (at least 3) to ensure statistical significance.
Maintain consistent cell concentrations across samples (e.g., 1 × 10⁶ cells/mL).
Use freshly prepared reagents to prevent degradation and variability.
Prepare DCFH-DA solutions under low light conditions to prevent premature oxidation.
Aliquot reagents to avoid repeated freeze-thaw cycles.
Set appropriate forward and side scatter parameters to properly gate neutrophil populations.
Conduct experiments under identical conditions, such as temperature, incubation times, and reagent batches.
Use standardized protocols for sample preparation and data analysis.
Work in a sterile environment to prevent bacterial contamination, which may alter results.
Regularly clean flow cytometry fluidics to avoid cross-contamination.